Table 1.
Treatment accepted (n=79) | Treatment refused (n=48) | |
---|---|---|
Patient demographics | ||
Male gendera | 92% | 77% |
African Americanb | 30% | 46% |
Mean agea (years) | 48.1 | 51.2 |
Employed | 37% | 25% |
Any college education | 57% | 58% |
Currently in a relationship | 26% | 17% |
HIV and HCV disease characteristics | ||
Mean CD4 countc (mm3) | 533 | 410 |
CD4 count≤200c | 1% | 21% |
Mean log10 HIV RNA (copies/mL) | 2.24 | 2.17 |
HIV RNA≤400 | 79% | 83% |
On ART | 91% | 96% |
HCV genotype 1 or 4 | 72% | 81% |
Mean log10 HCV RNA (copies/mL) | 6.09 | 6.24 |
Psychosocial functioning | ||
Depression (past 6 months) | 39% | 44% |
Other psychiatric disorder (past 6 months) | 24% | 20.8% |
Frequent alcohol use (past 6 months) | 8% | 15% |
Illicit drug use (past 6 months)a | 11% | 27% |
Mean ART adherence | 92% | 87% |
Any missed ART doses (past week) | 23% | 33% |
Any missed clinic appointments (past 6 months) | 34% | 33% |
Provider characteristics | ||
Number of coinfected patientsc | 309.6 | 132.0 |
Number of patients treated with IFN/RBVb | 43.8 | 34.9 |
Treat with small amounts of alcohol is okayc | 45% | 19% |
Treat only if patient's drug use stopped | 44% | 57% |
Treat only if patient's depression is in remissiona | 48% | 64% |
Confidence to treat HCVc | 3.4 | 2.9 |
HCV treatment outcome expectationsa | 4.3 | 4.0 |
p<0.05.
p<0.10.
p<0.01.
HCV, hepatitis C virus; ART, antiretroviral therapy; IFN/RBV, interferon/ribavirin.